Tuesday, May 30th | 5 Sivan 5777

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
May 20, 2016 3:12 am

Israeli Creator of Revolutionary System for Mobility-Impaired Patients Teams Up With Harvard to Develop Improved Model

avatar by Lea Speyer

Email a copy of "Israeli Creator of Revolutionary System for Mobility-Impaired Patients Teams Up With Harvard to Develop Improved Model" to a friend
A patient uses the ReWalk Robotics exoskeleton system. Photo: ReWalk Robotics.

A patient uses the ReWalk Robotics exoskeleton system. Photo: ReWalk Robotics.

The Israeli company behind a revolutionary system that enables people with mobility limitations to walk announced it is teaming up with a prestigious US university to develop the next generation of “exoskeletons.”

ReWalk Robotics revealed this week that it is partnering with Harvard University’s Wyss Institute to create an improved model.

“There is a great need in the healthcare system for lightweight, lower-cost wearable exoskeleton designs to support stroke patients, individuals diagnosed with Multiple Sclerosis and senior citizens who require mechanical mobility assistance. This collaboration will help create the next generation of exoskeleton systems, making life-changing technology available to millions of consumers across a host of patient populations,” said Larry Jasinski, CEO of ReWalk, in a statement.

Related coverage

May 29, 2017 11:02 am
1

Israeli Researchers Develop New ALS Treatment

JNS.org - Researchers at Israel’s Ben-Gurion University of the Negev (BGU) announced the development of a new treatment for amyotrophic lateral...

ReWalk, founded in 2001, has made it its mission to improve the quality of life of individuals who suffer from spinal-cord injuries and lower-limb disabilities. According to ReWalk, the soft suit prototypes developed by the Wyss Institute “transmit power to key joints of the legs with cable technologies powered with software and mechanics that are similar to the technologies used in the ReWalk system. The cables are connected to fabric-based designs that attach to the legs and foot, thus lending the name ‘soft suit.’”

According to a case study on the benefits of ReWalk’s exoskeleton system, published by the International Spinal Cord Society in January, after just six months of use, patients experienced enhanced motor skills and better bladder and bowel functioning, among other benefits.

ReWalk one of a small handful of FDA-approved exoskeleton systems currently on the market. The ReWalk soft suit exoskeleton is expected to be made available to the public before 2019.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner
  • Tim

    Note: I used to own RWLK stock and now own EKSO stock long.

    “ReWalk is the only FDA-approved exoskeleton system currently on the market.”

    False.

    “EKSO GT™ ROBOTIC EXOSKELETON CLEARED BY FDA FOR USE WITH STROKE AND SPINAL CORD INJURY PATIENTS” – April 4th 2016

    Furthermore, Ekso is the only exoskeleton approved for stroke, which Rewalk is not.

    Additionally, ReWalk is facing possible seizure, injunction, and/or civil money penalties because of non compliance with the FDA:

    http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm487328.htm

  • Lol something harvard did right

    Lol something harvard did right

  • Yaakov

    “Prestigious” — that’s the most important thing.

Algemeiner.com